CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
152 hedge funds and large institutions have $144M invested in Clovis Oncology, Inc. in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less capital invested
Capital invested by funds: $198M → $144M (-$54.2M)
Holders
152
Holding in Top 10
1
Calls
$5.25M
Puts
$3.96M
Top Buyers
| 1 | +$4.96M | |
| 2 | +$4.39M | |
| 3 | +$1.8M | |
| 4 |
Renaissance Technologies
New York
|
+$1.67M |
| 5 |
Two Sigma Investments
New York
|
+$1.38M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$3.61M | |
| 3 | -$2.88M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.15M |
| 5 |
Citigroup
New York
|
-$1.73M |